Changes to Oregon's CBN Rules

DEA Presents on Delta-8 Concerns!

FDA Stakeholder Call Outcome: A New Way Forward for Cannabidiol and Other Hemp Products

CBD Bills Reintroduced in 118th Congress

OLCC Leader Ousted in Agency Scandal

DEA Declares THCO a Schedule I Substance

FDA Requests Congressional Action on CBD Products